Search details
1.
Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus Challenges.
J Virol
; 92(11)2018 06 01.
Article
in English
| MEDLINE | ID: mdl-29514914
2.
Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens.
J Immunol
; 196(7): 3064-78, 2016 Apr 01.
Article
in English
| MEDLINE | ID: mdl-26944928
3.
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells.
BMC Microbiol
; 16(1): 152, 2016 07 16.
Article
in English
| MEDLINE | ID: mdl-27421762
4.
Association between magnitude of the virus-specific plasmablast response and disease severity in dengue patients.
J Immunol
; 190(1): 80-7, 2013 Jan 01.
Article
in English
| MEDLINE | ID: mdl-23203929
5.
Induction of neutralizing antibodies in rhesus macaques using V3 mimotope peptides.
Vaccine
; 34(24): 2713-21, 2016 05 23.
Article
in English
| MEDLINE | ID: mdl-27102818
6.
Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates.
Vaccine
; 34(30): 3500-7, 2016 06 24.
Article
in English
| MEDLINE | ID: mdl-27085173
7.
Attenuated nef DNA vaccine construct induces cellular immune response: role in HIV-1 multiprotein vaccine.
Immunol Lett
; 89(2-3): 207-14, 2003 Oct 31.
Article
in English
| MEDLINE | ID: mdl-14556980
8.
C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells.
Virus Res
; 179: 231-4, 2014 Jan 22.
Article
in English
| MEDLINE | ID: mdl-24246304
9.
Multimeric scaffolds displaying the HIV-1 envelope MPER induce MPER-specific antibodies and cross-neutralizing antibodies when co-immunized with gp160 DNA.
PLoS One
; 9(12): e113463, 2014.
Article
in English
| MEDLINE | ID: mdl-25514675
10.
Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent Clade B virus-like particle vaccine.
AIDS Res Hum Retroviruses
; 28(9): 1063-72, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22214267
11.
Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines.
Vaccine
; 27(32): 4337-49, 2009 Jul 09.
Article
in English
| MEDLINE | ID: mdl-19389453
12.
Viral sequence diversity: challenges for AIDS vaccine designs.
Expert Rev Vaccines
; 7(9): 1405-17, 2008 Nov.
Article
in English
| MEDLINE | ID: mdl-18980542
13.
Developing broadly reactive HIV-1/AIDS vaccines: a review of polyvalent and centralized HIV-1 vaccines.
Curr Pharm Des
; 13(19): 1957-64, 2007.
Article
in English
| MEDLINE | ID: mdl-17627529
14.
Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.
Virology
; 358(2): 334-46, 2007 Feb 20.
Article
in English
| MEDLINE | ID: mdl-17011011
15.
Virus-like particles: designing an effective AIDS vaccine.
Methods
; 40(1): 98-117, 2006 Sep.
Article
in English
| MEDLINE | ID: mdl-16997718
16.
Lentivirus-like particles without reverse transcriptase elicit efficient immune responses.
Curr HIV Res
; 4(4): 475-84, 2006 Oct.
Article
in English
| MEDLINE | ID: mdl-17073623
Results
1 -
16
de 16
1
Next >
>>